Russia Approves First Drug for Treatment Against COVID-19

Paramedics and members of the Emergencies Ministry wearing personal protective equipment push a stretcher into an ambulance while transporting a patient amid the CCP virus outbreak in the city of Tver, Russia, on May 28, 2020. Tatyana Makeyeva/Reuters

Russia granted approval to a drug for use against COVID-19, the first time authorities have given the green light to a medicine against the new disease caused by the CCP (Chinese Communist Party) virus.

Hospitals can soon begin giving favipiravir, a drug traditionally used against the flu, to patients in early June after approval by Russia’s Ministry of Health, the Russian Direct Investment Fund (RDIF), and ChemRar Group said on Saturday.